EDGAR Filing Documents for 0001193125-17-370839

Form 8-K - Current report:

SEC Accession No. 0001193125-17-370839

Filing Date

2017-12-15

Accepted

2017-12-15 17:03:56

Documents

Period of Report

2017-12-12

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d511932d8k.htm	8-K	20577
2	EX-1.1	d511932dex11.htm	EX-1.1	158090
3	EX-5.1	d511932dex51.htm	EX-5.1	6620
4	EX-99.1	d511932dex991.htm	EX-99.1	8619
5	EX-99.2	d511932dex992.htm	EX-99.2	9268
6	GRAPHIC	g511932g28y02.gif	GRAPHIC	3768
	Complete submission text file	0001193125-17-370839.txt		209723

Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139

Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 617-225-0096

PROTEOSTASIS THERAPEUTICS, INC. (Filer) CIK: 0001445283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-37695 | Film No.: 171259685
SIC: 2834 Pharmaceutical Preparations